Malini, 2012 - Google Patents
A study of maternal and perinatal outcome in premature rupture of membranes at termMalini, 2012
- Document ID
- 6093783654144845920
- Author
- Malini S
- Publication year
- Publication venue
- PQDT-Global
External Links
Snippet
BACKGROUND AND OBJECTIVESPremature rupture of membranes is a significant event which is unpredictable. As it can cause maternal complications like chorioamnionitis, increased operative procedures, puerperal sepsis and neonatal morbidity and mortality. The …
- 230000008774 maternal effect 0 title abstract description 95
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02411—Detecting, measuring or recording pulse rate or heart rate of foetuses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mercer et al. | Effects of placental transfusion on neonatal and 18 month outcomes in preterm infants: a randomized controlled trial | |
| Arias | Delayed delivery of multifetal pregnancies with premature rupture of membranes in the second trimester | |
| Khade et al. | Preterm premature rupture of membranes: maternal and perinatal outcome | |
| Nicholson et al. | The active management of risk in multiparous pregnancy at term: association between a higher preventive labor induction rate and improved birth outcomes | |
| Kawale et al. | Management of Hypertension in Elderly Pregnant Women with IVF Conception: A Case Report | |
| Nagaria | A study on feto-maternal outcome in patients with premature rupture of membranes | |
| Sharma et al. | Ruptured cornual ectopic pregnancy: a rare and challenging obstetric emergency | |
| Nicholson et al. | Active management of risk in nulliparous pregnancy at term: association between a higher preventive labor induction rate and improved birth outcomes | |
| Dudenhausen | Practical obstetrics | |
| Elmenam et al. | Bovine lactoferrin in preterm labor with sterile inflammation | |
| Malini | A study of maternal and perinatal outcome in premature rupture of membranes at term | |
| Flowers et al. | Cocaine intoxication associated with abruptio placentae | |
| Gurung et al. | Prevalence and Outcome of Cesarean Section at Gandaki Medical College Teaching Hospital and Research Centre, Pokhara, Nepal | |
| El-Sayed et al. | Perinatal outcomes of pregnancies with preterm premature rupture of membranes after 34 weeks of gestation | |
| Jha | Expectant Versus Active Management at Term Pregnancy with Prom | |
| Yusof | Case control study: incidence and risk factors of postpartum haemorrhage in primigravida | |
| Wright et al. | Problems During Labor and Delivery | |
| Akram | A Study of Maternal and Perinatal Outcome in Premature Rupture of Membranes at Term | |
| Frenken et al. | Accidental rupture of membranes and neonatal infection after labor induction with silicone or latex balloon catheters: A retrospective cohort study | |
| Nkobetchou et al. | Cervical ripening for a singleton fetus in breech prensentation at term: Comparison between mechanical and pharmaceutical methods | |
| Crean et al. | What All Nurses Need to Know About Pregnant and Postpartum Patients | |
| Al-Faiq et al. | Incidence and Outcome of Labor Induction among Mothers Who Delivered in Al-Sabeen Hospital Sana'a city, Yemen | |
| BODDU | A randomized controlled unmasked trial comparing safety and efficacy of oral misoprostol with intravenous oxytocin for induction in prelabour rupture of membranes at term | |
| Graham et al. | Preterm premature rupture of membranes (PPROM) | |
| Chen et al. | Prelabor Rupture of Membranes |